Results 31 to 40 of about 2,355 (177)

Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial

open access: yesIndian Dermatology Online Journal
Background: Phototherapy is the most commonly used treatment for vitiligo, with initial pigment appearing at the perifollicular site, eventually coalescing into uniform pigmentation due to melanocyte migration from hair follicles.
Sejal Bajoria   +6 more
doaj   +1 more source

Analysis of dermoscopic characteristics in vitiligo lesions treated with autologous non-cultured epidermal cell suspension transplantation: A prospective study

open access: yesPhotodiagnosis and Photodynamic Therapy
Background: Non-cultured epidermal cell suspension (NCES) transplantation, as a cellular grafting technique to treat stable vitiligo, is gaining wider acceptance among dermatologists.
Rongsi Sun   +5 more
doaj   +1 more source

Nonsurgical Repigmentation Therapies in Vitiligo [PDF]

open access: yesArchives of Dermatology, 1998
To assess the effectiveness and safety of nonsurgical repigmentation therapies in localized and generalized vitiligo by means of a meta-analysis.Computerized searches of bibliographic databases, a complementary manual literature search, and contacts with researchers and pharmaceutical firms.Predefined selection criteria were applied to both randomized ...
Njoo, M. D.   +4 more
openaire   +3 more sources

Comparative Efficacy and Safety of Tissue Grafting Versus ReCell Autologous Cell Suspension in Stable Vitiligo: A 12‐Month Retrospective Study

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 8, August 2026.
ABSTRACT Background Vitiligo surgery is often the last resort for treatment‐resistant lesions with stable conditions. Between tissue grafting (suction blister epidermal grafting [SBEG] and ultra‐thin split‐thickness skin grafting [UT‐STSG]) and cellular grafting (ReCell), large‐scale comparative data are lacking.
Dihui Lai   +7 more
wiley   +1 more source

CD8+ Tissue‐Resident Memory T Cells in Health and Disease

open access: yesMedComm, Volume 7, Issue 7, July 2026.
CD8+ TRM cells are at the center of immunity, mediating potent local innate and adaptive immune responses. While TRM cells mediate protective immunity against infections and tumors, they also contribute to pathological inflammation in autoimmune conditions.
Yu‐Han Ai   +13 more
wiley   +1 more source

Effects of high and low irradiance excimer light in repigmenting vitiligo: A single-center cross-sectional study

open access: yesDermatologica Sinica
Ultraviolet B (UVB) phototherapy is an important treatment modality for inducing repigmentation in vitiligo. Wavelength and fluence (dose; J/m2) are well-recognized parameters influencing phototherapy outcomes. Irradiance (power density; W/m2), the total
Ting-Ting Yang   +2 more
doaj   +1 more source

100 Most-Cited Articles in Vitiligo: A Bibliometric Analysis

open access: yesIndian Journal of Dermatology
Introduction: Vitiligo is a skin disease affecting melanocytes, characterised by the development of depigmented skin lesions. Methods: We used bibliometric analysis (BA) to identify high-quality research articles on vitiligo using criteria such as total ...
Zoé Gabrielle Attal   +3 more
doaj   +1 more source

Diagnostic findings in Various Cutaneous Hypopigmented Disorders: A Scoping Review [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Medical conditions can cause the skin to become hypopigmented or depigmented, mainly due to decreased production of melanin. Hypomelanosis is mainly benign and rarely malignant.
Sabiha Quazi   +3 more
doaj   +1 more source

Electrocautery Needling and the 308-nm Excimer Lamp: A Synergistic Combination for the Treatment of Stable Non-segmental Vitiligo

open access: yesDermatology and Therapy, 2020
Introduction Vitiligo is an acquired chronic depigmentation disorder caused by the destruction of melanocytes. Although various treatments have been proposed for the management of vitiligo, achieving repigmentation and preventing relapse remains ...
Lili Yang   +5 more
doaj   +1 more source

New‐Onset Vitiligo During Dupilumab Treatment: A Clinical Observation and Literature Review

open access: yesThe Clinical Respiratory Journal, Volume 20, Issue 7, July 2026.
Dupilumab rarely induces new‐onset vitiligo, even after discontinuation of the drug, potentially through the activation of the Th1/IFN‐γ pathway following IL‐4R blockade. Female sex and the use of topical corticosteroids are associated with improved outcomes, whereas discontinuing dupilumab alone does not ensure repigmentation.
Xuhui Pu, Suzhen Ju, Yanfang Yu
wiley   +1 more source

Home - About - Disclaimer - Privacy